News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
760,382 Results
Type
Article (51148)
Company Profile (299)
Press Release (708924)
Multimedia
Podcasts (97)
Webinars (17)
Section
Business (212871)
Career Advice (2121)
Deals (36662)
Drug Delivery (120)
Drug Development (84022)
Employer Resources (174)
FDA (17234)
Job Trends (15812)
News (360676)
Policy (34920)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2797)
Accelerated approval (33)
Adcomms (29)
Allergies (146)
Alliances (51771)
ALS (175)
Alzheimer's disease (1738)
Antibody-drug conjugate (ADC) (321)
Approvals (17502)
Artificial intelligence (551)
Autoimmune disease (166)
Automation (40)
Bankruptcy (374)
Best Places to Work (12099)
BIOSECURE Act (20)
Biosimilars (192)
Biotechnology (190)
Bladder cancer (159)
Brain cancer (60)
Breast cancer (659)
Cancer (4936)
Cardiovascular disease (420)
Career advice (1800)
Career pathing (39)
CAR-T (287)
CDC (49)
Celiac Disease (2)
Cell therapy (760)
Cervical cancer (38)
Clinical research (71601)
Collaboration (1770)
Company closure (4)
Compensation (1170)
Complete response letters (59)
COVID-19 (2843)
CRISPR (93)
C-suite (887)
Cystic fibrosis (144)
Data (6334)
Decentralized trials (2)
Denatured (36)
Depression (144)
Diabetes (516)
Diagnostics (6919)
Digital health (51)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (257)
Drug pricing (195)
Drug shortages (31)
Duchenne muscular dystrophy (235)
Earnings (92405)
Editorial (62)
Employer branding (21)
Employer resources (153)
Events (122518)
Executive appointments (1007)
FDA (20448)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1513)
Gene editing (203)
Generative AI (51)
Gene therapy (611)
GLP-1 (1033)
Government (4951)
Grass and pollen (6)
Guidances (385)
Healthcare (19965)
HIV (62)
Huntington's disease (46)
IgA nephropathy (83)
Immunology and inflammation (260)
Immuno-oncology (58)
Indications (113)
Infectious disease (3124)
Inflammatory bowel disease (199)
Inflation Reduction Act (14)
Influenza (120)
Intellectual property (254)
Interviews (324)
IPO (17013)
IRA (51)
Job creations (4058)
Job search strategy (1510)
JPM (57)
Kidney cancer (16)
Labor market (86)
Layoffs (568)
Leadership (34)
Legal (8511)
Liver cancer (95)
Longevity (15)
Lung cancer (672)
Lymphoma (380)
Machine learning (43)
Management (59)
Manufacturing (816)
MASH (170)
Medical device (14808)
Medtech (14865)
Mergers & acquisitions (20733)
Metabolic disorders (1326)
Multiple sclerosis (165)
NASH (16)
Neurodegenerative disease (335)
Neuropsychiatric disorders (93)
Neuroscience (3018)
Neurotech (1)
NextGen: Class of 2026 (6921)
Non-profit (4775)
Now hiring (67)
Obesity (628)
Opinion (278)
Ovarian cancer (168)
Pain (205)
Pancreatic cancer (235)
Parkinson's disease (291)
Partnered (34)
Patents (505)
Patient recruitment (505)
Peanut (58)
People (61813)
Pharmaceutical (68)
Pharmacy benefit managers (30)
Phase 1 (22291)
Phase 2 (31434)
Phase 3 (23488)
Pipeline (5409)
Policy (291)
Postmarket research (2742)
Preclinical (9491)
Press Release (67)
Prostate cancer (246)
Psychedelics (51)
Radiopharmaceuticals (293)
Rare diseases (864)
Real estate (6355)
Recruiting (70)
Regulatory (26005)
Reports (53)
Research institute (2557)
Resumes & cover letters (362)
Rett syndrome (27)
RNA editing (16)
RSV (81)
Schizophrenia (156)
Series A (244)
Series B (195)
Service/supplier (12)
Sickle cell disease (100)
Special edition (22)
Spinal muscular atrophy (162)
Sponsored (44)
Startups (3869)
State (2)
Stomach cancer (18)
Supply chain (109)
Tariffs (87)
The Weekly (59)
Vaccines (1057)
Venture capital (91)
Weight loss (417)
Women's health (95)
Worklife (18)
Date
Today (133)
Last 7 days (573)
Last 30 days (2218)
Last 365 days (30587)
2026 (3690)
2025 (30920)
2024 (36113)
2023 (41148)
2022 (52392)
2021 (57111)
2020 (55925)
2019 (48815)
2018 (36956)
2017 (33757)
2016 (33579)
2015 (39624)
2014 (33332)
2013 (28567)
2012 (30860)
2011 (31561)
2010 (29936)
Location
Africa (814)
Alabama (85)
Alaska (7)
Arizona (318)
Arkansas (14)
Asia (42464)
Australia (6990)
California (11440)
Canada (3316)
China (1149)
Colorado (494)
Connecticut (501)
Delaware (345)
Europe (92377)
Florida (1710)
Georgia (368)
Hawaii (3)
Idaho (65)
Illinois (920)
India (67)
Indiana (531)
Iowa (22)
Japan (440)
Kansas (130)
Kentucky (40)
Louisiana (27)
Maine (72)
Maryland (1432)
Massachusetts (8265)
Michigan (337)
Minnesota (653)
Mississippi (6)
Missouri (130)
Montana (32)
Nebraska (28)
Nevada (127)
New Hampshire (84)
New Jersey (3066)
New Mexico (30)
New York (3027)
North Carolina (1546)
North Dakota (8)
Northern California (5578)
Ohio (336)
Oklahoma (21)
Oregon (42)
Pennsylvania (2306)
Puerto Rico (24)
Rhode Island (50)
South America (1197)
South Carolina (68)
South Dakota (1)
Southern California (4456)
Tennessee (178)
Texas (1784)
United States (40951)
Utah (342)
Vermont (1)
Virginia (268)
Washington D.C. (84)
Washington State (957)
West Virginia (4)
Wisconsin (117)
Wyoming (2)
760,382 Results for "benchmark medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
WuXi Biologics Achieves ISO 20400 Certification, Setting Benchmark in Sustainable Procurement
January 5, 2026
·
3 min read
Press Releases
Clene to Participate at the Benchmark 14th Annual Discovery One-on-One Investor Conference
November 21, 2025
·
1 min read
Press Releases
The World’s First Quantum AIDD Benchmark for FIC Drug Discovery Is Released: From 10% Success Rate to Deterministic Design
January 7, 2026
·
1 min read
Press Releases
2025 Surgical Asset Management Industry Benchmark Report Reveals Hidden Risks in Sterile Processing Departments Nationwide
November 7, 2025
·
2 min read
Obesity
JPM26: After a Tough 2025, Biohaven Is Gearing Up To Challenge Goliath—Lilly
Biohaven has suffered a few setbacks in recent months, including an FDA rejection and a missed $150 million benchmark payment, but CEO Vlad Coric looked for the brighter side at JPM, specifically emphasizing a serendipitous discovery that could get the company in the obesity game.
January 20, 2026
·
3 min read
·
Dan Samorodnitsky
Biotech Beach
Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference
Belite Bio, Inc. today announced that the executive management team will participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference being held virtually on May 21 and 22, 2024.
May 14, 2024
·
1 min read
Genetown
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22nd, 2024, with a live fireside chat scheduled for 9:00-9:40 am ET.
May 16, 2024
·
1 min read
Press Releases
Vivani Medical, Inc. Announces Closing of Common Stock Offering
January 28, 2026
·
5 min read
Press Releases
Utah Medical Products, Inc. Announces Quarterly Dividend - February 4, 2026
February 5, 2026
·
1 min read
Press Releases
ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report
July 17, 2025
·
3 min read
1 of 76,039
Next
